305
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles

, , , , , & show all
Pages 552-567 | Received 28 Oct 2014, Accepted 26 Jan 2015, Published online: 10 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dongning Li, Jie Zhang & Xiaoyan Zhao. (2021) Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment. Cancer Investigation 39:8, pages 675-684.
Read now
Yu Sakurai & Hideyoshi Harashima. (2019) Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 16:9, pages 915-936.
Read now
Ives Charlie-Silva, Leonardo Fernandes Fraceto & Nathalie Ferreira Silva de Melo. (2018) Progress in nano-drug delivery of artemisinin and its derivatives: towards to use in immunomodulatory approaches. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 611-620.
Read now

Articles from other publishers (25)

Qiying Lv, Kai Chi, Xiaolei Shi, Miaodeng Liu, Xiaoye Li, Cheng Zhou, Lin Shi, Huiling Fan, Huan Liu, Jia Liu, Yan Zhang, Shuai Wang, Lin Wang & Zheng Wang. (2023) Nanozyme-like single-atom catalyst combined with artesunate achieves photothermal-enhanced nanocatalytic therapy in the near-infrared biowindow. Acta Biomaterialia 158, pages 686-697.
Crossref
Xingyue Wang, Peng Li, Xiangxiang Jing, Yun Zhou, Yongfu Shao, Min Zheng, Junrui Wang, Haitao Ran & Hailin Tang. (2022) Folate-modified erythrocyte membrane nanoparticles loaded with Fe3O4 and artemisinin enhance ferroptosis of tumors by low-intensity focused ultrasound. Frontiers in Oncology 12.
Crossref
Maciej Serda, Katarzyna Malarz, Julia Korzuch, Magdalena Szubka, Maciej Zubko & Robert Musioł. (2022) In Situ Cellular Localization of Nonfluorescent [60]Fullerene Nanomaterial in MCF-7 Breast Cancer Cells . ACS Biomaterials Science & Engineering 8:8, pages 3450-3462.
Crossref
Yanamandala Nitheesh, Rajesh Pradhan, Siddhant Hejmady, Rajeev Taliyan, Gautam Singhvi, Amit Alexander, Prashant Kesharwani & Sunil Kumar Dubey. (2021) Surface engineered nanocarriers for the management of breast cancer. Materials Science and Engineering: C 130, pages 112441.
Crossref
Dagmara Otto-Ślusarczyk, Magdalena Mielczarek-Puta & Wojciech Graboń. (2021) The Real Cytotoxic Effect of Artemisinins on Colon Cancer Cells in a Physiological Cell Culture Setting. How Composition of the Culture Medium Biases Experimental Findings. Pharmaceuticals 14:10, pages 976.
Crossref
Ujjwala KANDEKAR & Rohini PUJARİ. (2021) Nanocarrier based precise approaches for anticancer agents in treatment of breast cancer.. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
N A Saeed, I H Hamzah & S I Mahmood. (2021) The applications of nano-medicine in the breast cancer therapy. Journal of Physics: Conference Series 1853:1, pages 012061.
Crossref
Kiranmayi Patnala, Soumya Vishwas & Rama Rao Malla. 2021. A Theranostic and Precision Medicine Approach for Female-Specific Cancers. A Theranostic and Precision Medicine Approach for Female-Specific Cancers 271 287 .
Viney Lather, Rajendra Awasthi, Neelam Poonia, Harikesh Kalonia & Deepti Pandita. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs 163 194 .
Sibusiso Alven & Blessing Atim Aderibigbe. (2020) Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria. Pharmaceutics 12:8, pages 748.
Crossref
Yalan Wu, Qingping Zeng, Zhiwen Qi, Tao Deng & Fang Liu. (2020) Recent Progresses in Cancer Nanotherapeutics Design Using Artemisinins as Free Radical Precursors. Frontiers in Chemistry 8.
Crossref
Mohammad A. Ansari, Khan F. Badrealam, Asrar Alam, Saba Tufail, Gulshan Khalique, Mohammad J. Equbal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary & Faheem H. Pottoo. (2020) Recent Nano-based Therapeutic Intervention of Bioactive Sesquiterpenes: Prospects in Cancer Therapeutics. Current Pharmaceutical Design 26:11, pages 1138-1144.
Crossref
Xiao Xiao, Shuang Liang, Yajie Zhao, Dayu Huang, Bengang Xing, Ziyong Cheng & Jun Lin. (2020) Core–shell structured 5-FU@ZIF-90@ZnO as a biodegradable nanoplatform for synergistic cancer therapy. Nanoscale 12:6, pages 3846-3854.
Crossref
Sobiya Zafar, Gaurav Kumar Jain & Farhan Jalees Ahmad. 2020. Nanomedicine for Bioactives. Nanomedicine for Bioactives 201 229 .
Raju Saka & Naveen Chella. 2020. Sustainable Agriculture Reviews 44. Sustainable Agriculture Reviews 44 73 114 .
Peng Ji, Haiqin Huang, Shirui Yuan, Le Wang, Siqi Wang, Yiwei Chen, Na Feng, Hanitrarimalala Veroniaina, Ziheng Wu, Zhenghong Wu & Xiaole Qi. (2019) ROS‐Mediated Apoptosis and Anticancer Effect Achieved by Artesunate and Auxiliary Fe(II) Released from Ferriferous Oxide‐Containing Recombinant Apoferritin. Advanced Healthcare Materials 8:23, pages 1900911.
Crossref
Peng Zhang, Ming Zhang & Jia Geng. 2019. Nanomedicine in Brain Diseases. Nanomedicine in Brain Diseases 209 231 .
Thomas Efferth. (2018) Beyond malaria: The inhibition of viruses by artemisinin-type compounds. Biotechnology Advances 36:6, pages 1730-1737.
Crossref
Lei Wang, Yujie Hu, Yongwei Hao, Li Li, Cuixia Zheng, Hongjuan Zhao, Mengya Niu, Yanyan Yin, Zhenzhong Zhang & Yun Zhang. (2018) Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy. Journal of Controlled Release 286, pages 74-84.
Crossref
Shubhangi Mahajan, Abhimanyu Patharkar, Kaushik Kuche, Rahul Maheshwari, Pran Kishore Deb, Kiran Kalia & Rakesh K. Tekade. (2018) Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer. International Journal of Pharmaceutics 548:1, pages 540-558.
Crossref
M. L. Casais-Molina, C. Cab, G. Canto, J. Medina & A. Tapia. (2018) Carbon Nanomaterials for Breast Cancer Treatment. Journal of Nanomaterials 2018, pages 1-9.
Crossref
Lydia Ramzy, Maha Nasr, Abdelkader A. Metwally & Gehanne A.S. Awad. (2017) Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors. European Journal of Pharmaceutical Sciences 104, pages 273-292.
Crossref
Jong-Lyel Roh, Eun Hye Kim, Hyejin Jang & Daiha Shin. (2017) Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biology 11, pages 254-262.
Crossref
Blessing Aderibigbe. (2017) Design of Drug Delivery Systems Containing Artemisinin and Its Derivatives. Molecules 22:2, pages 323.
Crossref
Shine Augustine, Jay Singh, Manish Srivastava, Monica Sharma, Asmita Das & Bansi D. Malhotra. (2017) Recent advances in carbon based nanosystems for cancer theranostics. Biomaterials Science 5:5, pages 901-952.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.